A study has found that sirolimus-coated balloons vs thin drug-eluting stents in in-stent restenosis show similar favorable clinical outcomes.

The stent coatings can be broadly classified into three types: biocompatible coatings, drug-delivery coatings and polymer-free coatings/surfaces. Since metallic stent platforms will release ions ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in ...

Drug-coated balloon (DCB) angioplasty as the initial strategy for de novo coronary artery stenoses didn't measure up to ...

The FDA has approved a new type of stent designed specifically for infants and young children—including neonates born with congenital heart defects—that’s designed to expand in size as the ...

A cardiologist from Greenville, N.C.-based East Carolina University Health has performed the first patient implant of the world's first FDA-cleared, drug-eluting "bio envelope." John Catanzaro ...

CHARLOTTE — Newly approved medical technology offered at Atrium Health has helped a local man get back on his feet after a stent in his artery was blocked by scar tissue. Stan Ciepcielinski is ...

While the rhyme might be cute, pet allergies are anything but ... In fact, many routine drug treatments even specify this in their instruction leaflet. As Michelle Le Long, COO of pet insurance ...

or a Resolute Onyx zotarolimus-eluting stent (n = 1,198). Dual antiplatelet therapy was continued for at least 6 and 12 months in chronic and acute coronary syndromes, respectively. Total number of ...